Share Price and Basic Stock Data
Last Updated: July 22, 2025, 4:45 am
| PEG Ratio | 0.89 |
|---|
Quick Insight
Modi Naturals Ltd, operating in the competitive edible oils and solvent extraction industry, is currently trading at ₹490 with a market capitalization of ₹642 crore. The company's price-to-earnings (P/E) ratio of 20.7 suggests a premium valuation relative to its earnings, while a robust return on equity (ROE) of 29.2% indicates effective management in generating profits from shareholders' equity. However, the absence of net profit and operational metrics like OPM raises concerns about its financial health. With promoters holding a significant 69.09% stake, investor confidence appears solid, yet the lack of institutional backing (DIIs at 0.00%) could limit liquidity. Investors should proceed cautiously, weighing the potential for growth against the current lack of transparency in profitability.
Competitors of Modi Naturals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modi Naturals Ltd | 642 Cr. | 490 | 667/247 | 20.7 | 92.8 | 0.00 % | 18.6 % | 29.2 % | 10.0 |
| IEL Ltd | 62.3 Cr. | 4.78 | 7.10/3.36 | 145 | 3.44 | 0.00 % | 2.47 % | 1.87 % | 1.00 |
| Evexia Lifecare Ltd | 426 Cr. | 2.27 | 4.40/2.07 | 458 | 2.45 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 55.8 Cr. | 2.34 | 5.59/1.45 | 22.1 | 2.71 | 0.00 % | 6.94 % | 6.11 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 1,236 Cr. | 442 | 540/37.0 | 1,288 | 32.8 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| Industry Average | 9,455.47 Cr | 152.99 | 134.04 | 37.06 | 0.16% | 14.35% | 12.98% | 4.33 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 143.52 | 100.11 | 93.36 | 114.07 | 110.42 | 83.70 | 91.86 | 104.47 | 119.80 | 147.65 | 146.56 | 178.91 | 189.90 |
| Expenses | 142.16 | 95.49 | 91.48 | 113.19 | 112.57 | 81.23 | 89.58 | 105.72 | 114.22 | 134.39 | 133.22 | 165.61 | 173.79 |
| Operating Profit | 1.36 | 4.62 | 1.88 | 0.88 | -2.15 | 2.47 | 2.28 | -1.25 | 5.58 | 13.26 | 13.34 | 13.30 | 16.11 |
| OPM % | 0.95% | 4.61% | 2.01% | 0.77% | -1.95% | 2.95% | 2.48% | -1.20% | 4.66% | 8.98% | 9.10% | 7.43% | 8.48% |
| Other Income | 0.79 | 0.45 | 0.17 | 0.11 | 1.00 | 0.16 | 0.02 | 0.08 | 0.44 | 0.56 | 0.72 | 0.77 | 0.14 |
| Interest | 0.88 | 1.20 | 0.65 | 0.59 | 1.10 | 1.31 | 1.01 | 2.02 | 2.95 | 3.14 | 3.11 | 3.14 | 3.30 |
| Depreciation | 0.30 | 0.38 | 0.38 | 0.39 | 0.41 | 0.38 | 0.39 | 1.72 | 1.72 | 1.96 | 2.03 | 2.01 | 1.82 |
| Profit before tax | 0.97 | 3.49 | 1.02 | 0.01 | -2.66 | 0.94 | 0.90 | -4.91 | 1.35 | 8.72 | 8.92 | 8.92 | 11.13 |
| Tax % | 58.76% | 25.21% | 24.51% | 0.00% | -12.78% | 15.96% | 15.56% | -14.87% | 5.93% | 14.45% | 14.91% | 12.33% | 26.77% |
| Net Profit | 0.41 | 2.61 | 0.76 | 0.01 | -2.32 | 0.79 | 0.76 | -4.19 | 1.26 | 7.46 | 7.58 | 7.82 | 8.16 |
| EPS in Rs | 0.32 | 2.06 | 0.60 | 0.01 | -1.83 | 0.62 | 0.60 | -3.20 | 0.96 | 5.70 | 5.79 | 5.97 | 6.23 |
Last Updated: June 30, 2025, 5:32 am
Below is a detailed analysis of the quarterly data for Modi Naturals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 189.90 Cr.. The value appears strong and on an upward trend. It has increased from 178.91 Cr. (Dec 2024) to 189.90 Cr., marking an increase of 10.99 Cr..
- For Expenses, as of Mar 2025, the value is 173.79 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 165.61 Cr. (Dec 2024) to 173.79 Cr., marking an increase of 8.18 Cr..
- For Operating Profit, as of Mar 2025, the value is 16.11 Cr.. The value appears strong and on an upward trend. It has increased from 13.30 Cr. (Dec 2024) to 16.11 Cr., marking an increase of 2.81 Cr..
- For OPM %, as of Mar 2025, the value is 8.48%. The value appears strong and on an upward trend. It has increased from 7.43% (Dec 2024) to 8.48%, marking an increase of 1.05%.
- For Other Income, as of Mar 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.77 Cr. (Dec 2024) to 0.14 Cr., marking a decrease of 0.63 Cr..
- For Interest, as of Mar 2025, the value is 3.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.14 Cr. (Dec 2024) to 3.30 Cr., marking an increase of 0.16 Cr..
- For Depreciation, as of Mar 2025, the value is 1.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.01 Cr. (Dec 2024) to 1.82 Cr., marking a decrease of 0.19 Cr..
- For Profit before tax, as of Mar 2025, the value is 11.13 Cr.. The value appears strong and on an upward trend. It has increased from 8.92 Cr. (Dec 2024) to 11.13 Cr., marking an increase of 2.21 Cr..
- For Tax %, as of Mar 2025, the value is 26.77%. The value appears to be increasing, which may not be favorable. It has increased from 12.33% (Dec 2024) to 26.77%, marking an increase of 14.44%.
- For Net Profit, as of Mar 2025, the value is 8.16 Cr.. The value appears strong and on an upward trend. It has increased from 7.82 Cr. (Dec 2024) to 8.16 Cr., marking an increase of 0.34 Cr..
- For EPS in Rs, as of Mar 2025, the value is 6.23. The value appears strong and on an upward trend. It has increased from 5.97 (Dec 2024) to 6.23, marking an increase of 0.26.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 12:39 pm
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales | 443 | 474 | 418 | 399 | 663 |
| Expenses | 430 | 459 | 412 | 390 | 607 |
| Operating Profit | 13 | 15 | 5 | 9 | 56 |
| OPM % | 3% | 3% | 1% | 2% | 8% |
| Other Income | 4 | 1 | 2 | 1 | 1 |
| Interest | 1 | 2 | 4 | 8 | 12 |
| Depreciation | 1 | 1 | 2 | 4 | 8 |
| Profit before tax | 14 | 13 | 2 | -2 | 38 |
| Tax % | 25% | 28% | 42% | -21% | 18% |
| Net Profit | 11 | 9 | 1 | -1 | 31 |
| EPS in Rs | 8.31 | 7.40 | 0.85 | -1.05 | 23.70 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | -18.18% | -88.89% | -200.00% | 3200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -70.71% | -111.11% | 3400.00% |
Modi Naturals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | 66% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 49% |
| TTM: | 2349% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 67% |
| 3 Years: | 33% |
| 1 Year: | 81% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| Last Year: | 29% |
Last Updated: Unknown
Balance Sheet
Last Updated: July 25, 2025, 1:00 pm
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 |
| Reserves | 55 | 65 | 69 | 77 | 108 |
| Borrowings | 21 | 51 | 142 | 170 | 149 |
| Other Liabilities | 33 | 37 | 38 | 46 | 59 |
| Total Liabilities | 121 | 165 | 263 | 306 | 330 |
| Fixed Assets | 19 | 26 | 27 | 149 | 145 |
| CWIP | 0 | 0 | 91 | 0 | 16 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 102 | 139 | 144 | 157 | 169 |
| Total Assets | 121 | 165 | 263 | 306 | 330 |
Below is a detailed analysis of the balance sheet data for Modi Naturals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
- For Reserves, as of Mar 2025, the value is 108.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 108.00 Cr., marking an increase of 31.00 Cr..
- For Borrowings, as of Mar 2025, the value is 149.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 170.00 Cr. (Mar 2024) to 149.00 Cr., marking a decrease of 21.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 59.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 46.00 Cr. (Mar 2024) to 59.00 Cr., marking an increase of 13.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 330.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 306.00 Cr. (Mar 2024) to 330.00 Cr., marking an increase of 24.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 149.00 Cr. (Mar 2024) to 145.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 16.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 169.00 Cr.. The value appears strong and on an upward trend. It has increased from 157.00 Cr. (Mar 2024) to 169.00 Cr., marking an increase of 12.00 Cr..
- For Total Assets, as of Mar 2025, the value is 330.00 Cr.. The value appears strong and on an upward trend. It has increased from 306.00 Cr. (Mar 2024) to 330.00 Cr., marking an increase of 24.00 Cr..
However, the Borrowings (149.00 Cr.) are higher than the Reserves (108.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -36.00 | -137.00 | -161.00 | -93.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Debtor Days | 17 | 15 | 17 | 25 |
| Inventory Days | 72 | 95 | 98 | 125 |
| Days Payable | 8 | 12 | 21 | 33 |
| Cash Conversion Cycle | 81 | 98 | 94 | 117 |
| Working Capital Days | 58 | 73 | 85 | 103 |
| ROCE % | 14% | 3% | 3% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Diluted EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Cash EPS (Rs.) | 29.19 | 2.13 | 2.07 | 8.52 | 9.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Revenue From Operations / Share (Rs.) | 498.19 | 300.47 | 330.24 | 374.75 | 349.78 |
| PBDIT / Share (Rs.) | 43.00 | 7.68 | 5.49 | 12.78 | 13.15 |
| PBIT / Share (Rs.) | 37.12 | 4.51 | 4.26 | 11.66 | 12.06 |
| PBT / Share (Rs.) | 28.33 | -1.30 | 1.47 | 10.23 | 11.04 |
| Net Profit / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| NP After MI And SOA / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| PBDIT Margin (%) | 8.63 | 2.55 | 1.66 | 3.41 | 3.75 |
| PBIT Margin (%) | 7.45 | 1.50 | 1.28 | 3.11 | 3.44 |
| PBT Margin (%) | 5.68 | -0.43 | 0.44 | 2.73 | 3.15 |
| Net Profit Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| NP After MI And SOA Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| Return on Networth / Equity (%) | 25.52 | -1.52 | 1.30 | 12.13 | 15.49 |
| Return on Capital Employeed (%) | 24.71 | 3.32 | 3.09 | 17.91 | 20.85 |
| Return On Assets (%) | 9.40 | -0.45 | 0.40 | 5.66 | 8.67 |
| Long Term Debt / Equity (X) | 0.58 | 0.94 | 1.07 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 1.22 | 1.87 | 1.74 | 0.66 | 0.30 |
| Asset Turnover Ratio (%) | 2.08 | 1.41 | 1.95 | 3.31 | 0.00 |
| Current Ratio (X) | 1.22 | 1.24 | 1.53 | 1.59 | 2.06 |
| Quick Ratio (X) | 0.57 | 0.47 | 0.57 | 0.46 | 0.64 |
| Inventory Turnover Ratio (X) | 5.61 | 3.28 | 3.61 | 4.70 | 0.00 |
| Interest Coverage Ratio (X) | 4.89 | 1.32 | 1.97 | 8.96 | 12.85 |
| Interest Coverage Ratio (Post Tax) (X) | 3.65 | 0.82 | 1.30 | 6.19 | 9.12 |
| Enterprise Value (Cr.) | 601.08 | 422.48 | 433.31 | 295.48 | 112.19 |
| EV / Net Operating Revenue (X) | 0.90 | 1.06 | 1.04 | 0.62 | 0.25 |
| EV / EBITDA (X) | 10.51 | 41.33 | 62.37 | 18.26 | 6.74 |
| MarketCap / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| Price / BV (X) | 3.75 | 2.81 | 3.61 | 3.23 | 1.36 |
| Price / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| EarningsYield | 0.06 | -0.01 | 0.00 | 0.03 | 0.11 |
After reviewing the key financial ratios for Modi Naturals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 29.19, marking an increase of 27.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 498.19. It has increased from 300.47 (Mar 24) to 498.19, marking an increase of 197.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 43.00, marking an increase of 35.32.
- For PBIT / Share (Rs.), as of Mar 25, the value is 37.12. This value is within the healthy range. It has increased from 4.51 (Mar 24) to 37.12, marking an increase of 32.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from -1.30 (Mar 24) to 28.33, marking an increase of 29.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For PBDIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 2.55 (Mar 24) to 8.63, marking an increase of 6.08.
- For PBIT Margin (%), as of Mar 25, the value is 7.45. This value is below the healthy minimum of 10. It has increased from 1.50 (Mar 24) to 7.45, marking an increase of 5.95.
- For PBT Margin (%), as of Mar 25, the value is 5.68. This value is below the healthy minimum of 10. It has increased from -0.43 (Mar 24) to 5.68, marking an increase of 6.11.
- For Net Profit Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 8. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from -1.52 (Mar 24) to 25.52, marking an increase of 27.04.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 24.71, marking an increase of 21.39.
- For Return On Assets (%), as of Mar 25, the value is 9.40. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 9.40, marking an increase of 9.85.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.94 (Mar 24) to 0.58, marking a decrease of 0.36.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.87 (Mar 24) to 1.22, marking a decrease of 0.65.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.41 (Mar 24) to 2.08, marking an increase of 0.67.
- For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.57, marking an increase of 0.10.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.61. This value is within the healthy range. It has increased from 3.28 (Mar 24) to 5.61, marking an increase of 2.33.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 4.89, marking an increase of 3.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.65. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 3.65, marking an increase of 2.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 601.08. It has increased from 422.48 (Mar 24) to 601.08, marking an increase of 178.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.90, marking a decrease of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 41.33 (Mar 24) to 10.51, marking a decrease of 30.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For Price / BV (X), as of Mar 25, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.75, marking an increase of 0.94.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.06, marking an increase of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Modi Naturals Ltd:
- Net Profit Margin: 4.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.71% (Industry Average ROCE: 14.35%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.52% (Industry Average ROE: 12.98%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.7 (Industry average Stock P/E: 134.04)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.68%
About the Company - Qualitative Analysis
Modi Naturals Ltd. is a Public Limited Listed company incorporated on 06/07/1974 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L15142DL1974PLC007349 and registration number is 007349. Currently Company is involved in the business activities of Manufacture of vegetable oils and fats excluding corn oil. Company's Total Operating Revenue is Rs. 338.01 Cr. and Equity Capital is Rs. 13.31 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 405, Deepali Building, 92, Nehru Place, New Delhi Delhi 110019 | investors@modinaturals.com http://www.modinaturals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Modi | Chairman & Managing Director |
| Mr. Akshay Modi | Joint Managing Director |
| Mrs. Aditi Modi | Whole Time Director |
| Mr. Ankit Garg | Independent Director |
| Mrs. Ankita Singal | Independent Director |
| Mr. Udit Jain | Independent Director |
FAQ
What is the intrinsic value of Modi Naturals Ltd?
Modi Naturals Ltd's intrinsic value (as of 26 July 2025) is 457.71 6.59% lower the current market price of 490.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 642 Cr. market cap, FY2025-2026 high/low of 667/247, reserves of 108 Cr, and liabilities of 330 Cr.
What is the Market Cap of Modi Naturals Ltd?
The Market Cap of Modi Naturals Ltd is 642 Cr..
What is the current Stock Price of Modi Naturals Ltd as on 26 July 2025?
The current stock price of Modi Naturals Ltd as on 26 July 2025 is 490.
What is the High / Low of Modi Naturals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Modi Naturals Ltd stocks is ₹667/247.
What is the Stock P/E of Modi Naturals Ltd?
The Stock P/E of Modi Naturals Ltd is 20.7.
What is the Book Value of Modi Naturals Ltd?
The Book Value of Modi Naturals Ltd is 92.8.
What is the Dividend Yield of Modi Naturals Ltd?
The Dividend Yield of Modi Naturals Ltd is 0.00 %.
What is the ROCE of Modi Naturals Ltd?
The ROCE of Modi Naturals Ltd is 18.6 %.
What is the ROE of Modi Naturals Ltd?
The ROE of Modi Naturals Ltd is 29.2 %.
What is the Face Value of Modi Naturals Ltd?
The Face Value of Modi Naturals Ltd is 10.0.